#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thromboangiitis obliterans Graft versus host disease Burkitt's lymphoma Breast cancer metastatic Glioblastoma Leiomyosarcoma Waldenstrom's macroglobulinaemia Waldenstrom's macroglobulinaemia recurrent Cognitive disorder Glioma Oropharyngeal cancer recurrent Pulmonary fibrosis White matter lesion Bladder cancer Neuroendocrine carcinoma More trials…

    Learn about Rare Diseases

    Chondrosarcoma metastatic – Basic Information Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Treatment Familial haemophagocytic lymphohistiocytosis – Basic Information Arterial tortuosity syndrome Leukoencephalopathy – Treatment Leiomyosarcoma metastatic – Treatment Alveolar rhabdomyosarcoma – Diagnostics Chronic granulomatous disease Andersen-Tawil syndrome – Life with Disease Thrombotic thrombocytopenic purpura – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tas3351 Belinostat Estriol Milvexian Dermatophagoides Farinae Calcium Folinate Cefuroxime Contezolid Sodium Thiosulfate Bendamustine Ceralasertib Ulonivirine Vimseltinib Avalglucosidase Alfa Hyoscine L-Histidine Hydrochloride Utreloxastat Tisagenlecleucel Atidarsagene Autotemcel Human Serum Albumin 5% More therapies…

    Learn about Your Condition

    Leukoencephalopathy Diabetic nephropathy Vertebrobasilar stroke Muscle injury Postpartum haemorrhage Paraganglion neoplasm Vesicoureteric reflux Progressive multiple sclerosis Vascular calcification Micrographic skin surgery ROHHAD syndrome Lung neoplasm malignant Iron overload Acute HIV infection Angelman's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. CHU de Rouen – Hôpital Charles Nicolle

CHU de Rouen – Hôpital Charles Nicolle

37 boulevard Gambetta, Rouen, 76000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Regorafenib and Maintenance Chemotherapy for Newly Diagnosed Ewing Sarcoma Patients with Metastatic Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Cyclophosphamide
    • Vinorelbine
    Denmark France The Netherlands Norway Spain

  • Study on Long-Term Effects of Efanesoctocog Alfa in Preventing Joint Bleeds in Patients with Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Efanesoctocog Alfa
    Croatia Czechia France Germany Ireland Italy +2

  • Study of Epoetin Alfa for Critically Ill Patients with Traumatic Injury

    Recruiting

    3 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Epoetin Alfa
    Belgium Finland France Germany Ireland Slovenia

  • Study of Oxaliplatin, Nivolumab, and Trifluridine/Tipiracil for Patients with Advanced Gastric, Esophageal, or Gastroesophageal Junction Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer recurrent
    • Oesophageal carcinoma
    • Gastric cancer
    Investigated Drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    France

  • Randomized phase III adjuvant capecitabine plus temozolomide versus surveillance in patients with resected stage I‑III pancreatic neuroendocrine tumors

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic neuroendocrine tumour
    Investigated Drugs:
    • Capecitabine
    • Temozolomide
    France

  • Study on Chemotherapy with Levoleucovorin, Capecitabine, and Folinic Acid for Patients Aged 70+ After Stage III Colon Cancer Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer
    Investigated Drugs:
    • Levoleucovorin
    • Capecitabine
    • Fluorouracil
    Belgium France

  • Study on Hormonal Treatment with Leuprorelin Acetate for Prostate Cancer Patients at High Risk of Recurrence After Surgery

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Leuprorelin Acetate
    France

  • Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Durvalumab
    Bulgaria France Hungary Italy The Netherlands Poland +2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!